Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2021
IDO1 scavenges reactive oxygen species in myeloid-derived suppressor cells to prevent graft-versus-host diseaseJi-Min Ju, Giri Nam, Young-Kwan Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 28, 2014
CD161(+) T cells as predictive markers for acute graft-versus-host diseaseSung-Eun Lee, Ji-Young Lim, Jae-Ho Yoon, et al.
International Journal of Stem Cells|January 1, 2019
Predictive Role of Circulating Immune Cell Subtypes Early after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute LeukemiaTae Woo Kim, Sung-Soo Park, Ji-Young Lim, et al.
Biomed Research International|March 8, 2018
Circulating CD3+CD4+CD161+ Cells Are Associated with Early Complications after Autologous Stem Cell Transplantation in Multiple MyelomaSung-Eun Lee, Ji-Young Lim, Da-Bin Ryu, et al.
Cancer Immunology, Immunotherapy : CII|June 26, 2016
Circulating immune cell phenotype can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myelomaSung-Eun Lee, Ji-Young Lim, Da-Bin Ryu, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 3, 2016
Clinical significance of pre-transplant circulating CD3+ CD4+ CD161+ cell frequency on the occurrence of neutropenic infections after allogeneic stem cell transplantationTae Woo Kim, Sung-Eun Lee, Ji-Young Lim, et al.
Annals of Hematology|June 26, 2018
Low frequency of CD3+CD4+CD161+ T cells correlates with the occurrence of infections in refractory/relapsed multiple myeloma patients receiving lenalidomide plus low-dose dexamethasone treatmentSung-Eun Lee, Ji-Young Lim, Da-Bin Ryu, et al.
Annals of Hematology|September 7, 2011
Circulating IL-17 levels during the peri-transplant period as a predictor for early leukemia relapse after myeloablative allogeneic stem cell transplantationByung-Sik Cho, Ji-Young Lim, Seung-Ah Yahng, et al.
Journal for Immunotherapy of Cancer|February 9, 2019
Different role of circulating myeloid-derived suppressor cells in patients with multiple myeloma undergoing autologous stem cell transplantationSung-Eun Lee, Ji-Young Lim, Tae Woo Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 8, 2009
High levels of B cell activating factor during the peritransplantation period are associated with a reduced incidence of acute graft-versus-host disease following myeloablative allogeneic stem cell transplantationByung-Sik Cho, Chang-Ki Min, Hee-Je Kim, et al.
Pageof 13